Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-08-16 16:06:50
Reporting Period:
Accepted Time:
2019-08-16 16:06:50
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235644 J Gerard Michel C/o Vericel Corporation
64 Sidney Street
Cambridge MA 02139
Cfo And Vp, Corp. Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-14 17,000 $3.02 140,182 No 4 M Direct
Common Stock Disposition 2019-08-14 17,000 $16.62 123,182 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-08-14 17,000 $0.00 17,000 $3.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
69,769 2025-01-05 No 4 M Direct
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018.
  2. These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.